dsm-firmenich Reports Progress on Share Repurchase Program
News related to:dsm-firmenich · 2 min read
dsm-firmenich, a Swiss company specializing in nutrition, health, and beauty, has announced progress on its share repurchase program aimed at reducing its issued capital and covering share-based compensation plans. The company began its share repurchase program on March 12, 2026, with a target of €500 million to reduce its capital and an additional €40 million to cover commitments under its share-based compensation plans.
As of September 11, 2026, dsm-firmenich has repurchased a total of 6,402,212 shares, amounting to €466.8 million. During the period from September 7 to September 11, 2026, the company repurchased 385,000 shares at an average price of €92.07 per share, totaling €35.4 million. The repurchase of €40 million worth of shares to cover commitments under the Group’s share-based compensation plans was completed on March 23, 2026.
The company’s share repurchase program is part of its ongoing efforts to optimize capital structure and align with its strategic goals. The €500 million share repurchase program to reduce the Group’s issued capital is intended to be completed by the end of the third quarter of 2026.
dsm-firmenich, known for its innovation in nutrition, health, and beauty, continues to reinvent and manufacture vital nutrients, flavors, and fragrances for the world’s growing population. The company’s comprehensive range of solutions, with natural and renewable ingredients, and its renowned science and technology capabilities, are designed to create essential products for life, desirable for consumers, and more sustainable for people and the planet.
The company’s commitment to reducing its issued capital through share repurchases reflects its strategic focus on optimizing its capital structure and enhancing shareholder value. By repurchasing shares, dsm-firmenich aims to reduce the number of outstanding shares, potentially increasing the value of the remaining shares and improving the company’s financial metrics.
With operations in nearly 60 countries and revenues of more than €9 billion for its Continuing Operations following the divestment of Animal Nutrition & Health, dsm-firmenich continues to drive progress in the fields of nutrition, health, and beauty. The company’s diverse team of nearly 21,000 employees works tirelessly to bring essential products to life, benefiting billions of people worldwide.